The effect of Dydrogesterone and micronized progesterone on threatend abortio

Phase 3

Recruiting

• Conditions: Threatened abortion.; Threatened abortion; O20.0

• Registration Number: IRCT20120104008611N10
• Lead Sponsor: Qazvin University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

Gestational age 6 to 13 weeks
Observation of fetal heart rate
Vaginal bleeding
Absence of uterine anomalies
Absence fetal anomalies

Exclusion Criteria

Breast carcinoma
Severe liver problems
Genital carcinoma
Thromboembolic disorders
Epilepsy
Diabetes
Hypertension

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Preeclampsia. Timepoint: Up to 28 weeks monthly and until 36 weeks every two weeks and thereafter weekly until delivery. Method of measurement: Sphygmometer.;Gestational Diabetes. Timepoint: Up to 28 weeks monthly and until 36 weeks every two weeks and then weekly until delivery. Method of measurement: Glucose tolerance test.;Preterm labor. Timepoint: Up to 28 weeks monthly and until 36 weeks every two weeks and then weekly until delivery. Method of measurement: Tocometry of uterus and delivery before 37 weeks of pregnancy.;Low birth weight. Timepoint: Weight immediately after birth. Method of measurement: Pediatric scales.;Abortion under 20 weeks of pregnancy. Timepoint: Every week from the start of the intervention up to 20 weeks of pregnancy. Method of measurement: Questionnaire.